EphrinB2 upregulation after RT was also confirmed in our MOC2 HNSCC tumor model, and ephrinB2-expressing vascular cells were observed to be more proliferative as determined by Ki-67 expression (Suppl. The gene discussed is EFNB2; the disease is head and neck squamous cell carcinoma.